Bildkälla: Stockfoto

Medivir: Start of Second Part of MIV-818’s Phase I/IIa Trial - Redeye

Redeye comments on the start of the next part of MIV-818’s clinical trial. We find it encouraging that everything is going ahead according to schedule.

Redeye comments on the start of the next part of MIV-818’s clinical trial. We find it encouraging that everything is going ahead according to schedule.
Börsvärldens nyhetsbrev
ANNONSER